Certified by Founder Lodge
Ablaze Pharmaceuticals
China - Shanghai
START UP
1 Disclosed Funding Rounds $75,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Ablaze Pharma is a clinical stage Biopharmaceutical Company which is focused on the developing innovative Targeted Radiotherapy (TRT) to benefit cancer patients in China.
Date | Round | Raised | Participating Investors |
---|---|---|---|
November, 29 ,2021 | Series A | $75,000,000 |